Klebanoff MJ, Li P, Long JA, Doshi JA "Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists" , JAMA: 2025

Li P, Geng Z, Benson C, Patel C, Doshi JA "Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia" , Advances in Therapy, 42(2): 2025,1251-1264

Doshi JA, Li P, Klebanoff MJ, Lin JK "Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs" , JAMA Health Forum, 6(5): 2025,e251387-e251387

Huntington SF, Rhodes JM, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Marx SE, Doshi JA "Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia" , JCO Oncology Practice, 21(8): 2025,1124-1133

Doshi JA, Li P, Asthana S, Lin JK "Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan" , JCO Oncology Practice: 2025,OP-24-00937

Li P, Lin JK, Klebanoff MJ, Palkar R, Chahin S, Doshi JA "Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis" , Neurology Clinical Practice, 15(6): 2025

Lin JK, Niu J, Giordano SH, Li P, Snyder RA, Liao K, Li M, Aparicio A, Chapin W, Zhang J, Xiang J, Perera N, Pain D, Guerra CE, Doshi JA "Racial and ethnic disparities along the treatment cascade among Medicare fee-for-service beneficiaries with metastatic breast, colorectal, lung, and prostate cancers" , Journal of Clinical Oncology: 2025

Thirukumaran CP, Schloemann DT, Doshi JA, Fiscella KA, Ricciardi BF, Rosenthal MB "Opioid Cap Laws and Opioid Prescriptions After Total Joint Replacements in Older Adults" , JAMA Network Open, 8(4): 2025,e254448-e254448

Paruzzo L, Eshaghi K, Ghilardi G, Doucette A, Ho M, Carturan A, Vogl DT, Waxman AJ, Kapur S, Fardella E, Pucillo M, Imparato A, Stella F, Guruprasad P, De Souza VB, Maillie L, Kaparis S, Bouvier S, Cohen AD, Doshi JA, Porter DL, Garfall AL, Stadtmauer EA, Guerra CE, Adaniya SP, Ruella M "Access and outcomes of racial and ethnic minority populations receiving commercial anti-BCMA CART for myeloma" , Blood Immunology & Cellular Therapy: 2025,100007

Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA "Real‐World Analysis of Adverse Event Rates after Initiation of Ibrutinib among Medicare Beneficiaries with Chronic Lymphocytic Leukemia" , Cancer Medicine, 13(2): 2024,e6953